title: Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism.
authors.forename: Matthis
authors.initials: M
authors.lastname: Synofzik
authors.forename: Friedrich
authors.initials: F
authors.lastname: Asmus
authors.forename: Matthias
authors.initials: M
authors.lastname: Reimold
authors.forename: Ludger
authors.initials: L
authors.lastname: Schöls
authors.forename: Daniela
authors.initials: D
authors.lastname: Berg
mesh_terms: D000339:Affect / Q000187:drug effects*; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D011877:Radionuclide Imaging; D016896:Treatment Outcome
chemical_list: D015259:Dopamine Agents; D007211:Indoles; C046649:ropinirole; D007980:Levodopa; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase; C413027:POLG protein, human